Abstract
Positron emission tomography (PET) using FDG tracer in cancer imaging relies on the increased glucose metabolism of tumor cells. We examined a fluorescent glucose, 2-NBDG, as an optical analog of FDG-PET for Barrett's Esophagus (BE)-related neoplasia. We performed a series of experiments using BE cell lines and a unique model, endoscopic mucosal resection (EMR) tissue, to assess the mechanism and feasibility of 2-NBDG as a probe for esophageal dysplasia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
